#152709

Dual DNA-PK/PI3K inhibitor KU-0060648 Small Molecule (Tool Compound)

Please Enter Your Email ID
Email ID

Cat. #152709

Dual DNA-PK/PI3K inhibitor KU-0060648 Small Molecule (Tool Compound)

Cat. #: 152709

Sub-type: Inhibitor

Availability: Please enquire for quantities and pricing

Application: KU-0060648 enhances the anti-tumour activity of etoposide in both MCF7 and SW620 xenograft models, and has single-agent activity in the MCF7 xenograft model. KU-0060648 exhibits differential effects on growth inhibition, but is not profoundly cytotoxic in a panel of human cancer cell lines. It inhibits DNA-PK and PI-3K with greater potency in MCF7 than SW620 cell using cell-based assays. Five-day exposure to 1 mM KU-0060648 inhibits cell proliferation by more than 95% in MCF7 cells but only b...

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Laurent Rigoreau

Institute: Newcastle University

Tool Details
Handling
Target Details
Application Details
References

Tool Details

*FOR RESEARCH USE ONLY

  • Tool name: Dual DNA-PK/PI3K inhibitor KU-0060648 Small Molecule (Tool Compound)
  • Research fields: Cancer;Cell biology
  • Molecular formula: C33H34N4O4S
  • Tool sub type: Inhibitor
  • Primary target: Dual PI 3-K and DNA-PK inhibitor
  • Description: KU-0060648 is a dual PI3-K and DNA-PK inhibitor (IC50 values are <0.1, 0.5, 4 and 19 nM for PI 3-Kd, PI 3-K?, PI 3-Ka and DNA-PK respectively). It inhibits proliferation of MCF7 cells in vitro and delays growth of MCF7 xenografts in mice. KU-0060648 can also enhance CRISP-Cas9-mediated homology-directed repair (HDR) efficiency, and attenuate nonhomologous end-joining (NHEJ).
  • Application: KU-0060648 enhances the anti-tumour activity of etoposide in both MCF7 and SW620 xenograft models, and has single-agent activity in the MCF7 xenograft model. KU-0060648 exhibits differential effects on growth inhibition, but is not profoundly cytotoxic in a panel of human cancer cell lines. It inhibits DNA-PK and PI-3K with greater potency in MCF7 than SW620 cell using cell-based assays. Five-day exposure to 1 mM KU-0060648 inhibits cell proliferation by more than 95% in MCF7 cells but only b...
  • Purpose: Inhibitor
  • Molecular weight: 582.71
  • Solubility: Soluble to 100 mM in 2eq.HCl

Handling

  • Purity: 582.71 g/mol
  • Storage conditions: Store at -20° C
  • Shipping conditions: Dry Ice

Target Details

  • Primary target: Dual PI 3-K and DNA-PK inhibitor
  • Ic50: inhibitor of DNA-PK and PI3KÎą, PI3Kβ, PI3Kδ with IC50 of 8.6 nM and 4 nM, 0.5 nM, 0.1 nM respectively, less inhibition of PI3KÎł with IC50 of 0.59 ÎźM.

Application Details

  • Application: KU-0060648 enhances the anti-tumour activity of etoposide in both MCF7 and SW620 xenograft models, and has single-agent activity in the MCF7 xenograft model. KU-0060648 exhibits differential effects on growth inhibition, but is not profoundly cytotoxic in a panel of human cancer cell lines. It inhibits DNA-PK and PI-3K with greater potency in MCF7 than SW620 cell using cell-based assays. Five-day exposure to 1 mM KU-0060648 inhibits cell proliferation by more than 95% in MCF7 cells but only b...

References

  • Robert et al. 2015. Genome Med. 7(1):93. PMID: 26307031.
  • Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing.
  • Munck et al. 2012. Mol Cancer Ther. 11(8):1789-98. PMID: 22576130.
  • Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K.